Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Cerilliant
US Army
Boehringer Ingelheim
Deloitte
Julphar
QuintilesIMS
Novartis
AstraZeneca
Fish and Richardson

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,074,430

« Back to Dashboard

Summary for Patent: 7,074,430
Title:Controlled release tramadol tramadol formulation
Abstract:A controlled release preparation for oral administration contains tramadol, or a pharmaceutically acceptable salt thereof, as active ingredient.
Inventor(s): Miller; Ronald Brown (Basel, CH), Malkowska; Sandra Therese Antoinette (Cambridgeshire, GB), Wimmer; Walter (Limburg, DE), Hahn; Udo (Nentershausen, DE), Leslie; Stewart Thomas (Cambridge, GB), Smith; Kevin John (Cambridge, GB), Winkler; Horst (Linter, DE), Prater; Derek Allan (Cambridge, GB)
Assignee: Euro-Celtique S.A. (Luxembourg, LU)
Application Number:09/800,204
Patent Claim Types:
see list of patent claims
Compound; Dosage form; Formulation;

Drugs Protected by US Patent 7,074,430

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 7,074,430

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 138566 ➤ Subscribe
Austria 172376 ➤ Subscribe
Austria 184786 ➤ Subscribe
Austria 196079 ➤ Subscribe
Austria 201989 ➤ Subscribe
Austria 212224 ➤ Subscribe
Austria 221375 ➤ Subscribe
Austria 303140 ➤ Subscribe
Austria 306909 ➤ Subscribe
Austria 3413 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Johnson and Johnson
McKinsey
Cipla
QuintilesIMS
McKesson
Moodys
Federal Trade Commission
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot